BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25990846)

  • 1. Treatment outcome and patterns of failure in patients of non-pineal supratentorial primitive neuroectodermal tumor: review of literature and clinical experience form a regional cancer center in north India.
    Biswas A; Mallick S; Purkait S; Roy S; Sarkar C; Bakhshi S; Singh M; Julka PK; Rath GK
    Acta Neurochir (Wien); 2015 Jul; 157(7):1251-66. PubMed ID: 25990846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome and patterns of failure in patients of pinealoblastoma: review of literature and clinical experience from a regional cancer centre in north India.
    Biswas A; Mallick S; Purkait S; Gandhi A; Sarkar C; Singh M; Julka PK; Rath GK
    Childs Nerv Syst; 2015 Aug; 31(8):1291-304. PubMed ID: 26040934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Outcome in Patients with Primary Central Nervous System Germ Cell Tumour: Clinical Experience from a Regional Cancer Centre in North India.
    Biswas A; Julka PK; Bakhshi S; Singh M; Rath GK
    Pediatr Neurosurg; 2017; 52(4):240-249. PubMed ID: 28538229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial atypical teratoid rhabdoid tumor: current management and a single institute experience of 15 patients from north India.
    Biswas A; Julka PK; Bakhshi S; Suri A; Rath GK
    Acta Neurochir (Wien); 2015 Apr; 157(4):589-96. PubMed ID: 25646852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
    Chintagumpala M; Hassall T; Palmer S; Ashley D; Wallace D; Kasow K; Merchant TE; Krasin MJ; Dauser R; Boop F; Krance R; Woo S; Cheuk R; Lau C; Gilbertson R; Gajjar A
    Neuro Oncol; 2009 Feb; 11(1):33-40. PubMed ID: 18796696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.
    Jakacki RI; Burger PC; Kocak M; Boyett JM; Goldwein J; Mehta M; Packer RJ; Tarbell NJ; Pollack IF
    Pediatr Blood Cancer; 2015 May; 62(5):776-83. PubMed ID: 25704363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pineal and nonpineal supratentorial primitive neuroectodermal tumors.
    Jakacki RI
    Childs Nerv Syst; 1999 Oct; 15(10):586-91. PubMed ID: 10550590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
    Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
    Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
    Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.
    Biswas B; Agarwala S; Shukla NK; Deo S; Sharma D; Thulkar S; Vishnubhatla S; Bakhshi S
    Ann Thorac Surg; 2013 Dec; 96(6):2006-14. PubMed ID: 24035307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
    Timmermann B; Kortmann RD; Kühl J; Meisner C; Dieckmann K; Pietsch T; Bamberg M
    J Clin Oncol; 2002 Feb; 20(3):842-9. PubMed ID: 11821469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.
    Pizer BL; Weston CL; Robinson KJ; Ellison DW; Ironside J; Saran F; Lashford LS; Tait D; Lucraft H; Walker DA; Bailey CC; Taylor RE
    Eur J Cancer; 2006 May; 42(8):1120-8. PubMed ID: 16632346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supratentorial primitive neuroectodermal tumors: a Canadian pediatric brain tumor consortium report.
    Johnston DL; Keene DL; Lafay-Cousin L; Steinbok P; Sung L; Carret AS; Crooks B; Strother D; Wilson B; Odame I; Eisenstat DD; Mpofu C; Zelcer S; Huang A; Bouffet E
    J Neurooncol; 2008 Jan; 86(1):101-8. PubMed ID: 17619825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel case of a CAT to AAT transversion in codon 179 of the p53 gene in a supratentorial primitive neuroectodermal tumor harbored by a young girl. Case report and review of the literature.
    Postovsky S; Ben Arush MW; Elhasid R; Davidson S; Leshanski L; Vlodavsky E; Guilburd JN; Amikam D
    Oncology; 2003; 65(1):46-51. PubMed ID: 12837982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor.
    Paulino AC; Cha DT; Barker JL; Lo S; Manera RB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1171-6. PubMed ID: 15001261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.